Toward a gene therapy for neurological and somatic MPSIIIA

Mucopolysaccharidosis Type IIIA (MPSIIIA) represents an unmet medical need. MPSIIIA shares with many other lysosomal storage disorders (LSD) the characteristic of being a severe neurodegenerative disease accompanied by mild somatic involvement. Thus, the main target organ for the development of new...

Descripción completa

Detalles Bibliográficos
Autores principales: Haurigot, Virginia, Bosch, Fatima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2013
Materias:
Addendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3927492/
https://www.ncbi.nlm.nih.gov/pubmed/25003015
http://dx.doi.org/10.4161/rdis.27209

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3927492/
https://www.ncbi.nlm.nih.gov/pubmed/25003015
http://dx.doi.org/10.4161/rdis.27209

Ejemplares similares